LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)
China flag China · Delayed Price · Currency is CNY
8.58
-0.24 (-2.72%)
Sep 10, 2026, 3:04 PM CST

SHE:002644 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
634.61524.49397.89406.04397.85374.94
Trading Asset Securities
----2-
Cash & Short-Term Investments
634.61524.49397.89406.04399.85374.94
Cash Growth
65.21%31.82%-2.01%1.55%6.64%-17.06%
Accounts Receivable
416.88474.08413.57382.65435.88344.8
Other Receivables
31.319.4145.5950.562.9812.34
Receivables
448.18493.49459.17433.15498.87357.14
Inventory
308.42289.84339.99369.72363.26258.83
Prepaid Expenses
-0.120.040.9--
Other Current Assets
30.8424.7924.7929.064243.72
Total Current Assets
1,4221,3331,2221,2391,3041,035
Property, Plant & Equipment
976.38986.961,0321,0621,0681,092
Long-Term Investments
66.7769.9355.6664.168.6771.65
Goodwill
9.019.019.019.019.014.47
Other Intangible Assets
71.9173.5576.8779.5576.7971.96
Long-Term Deferred Tax Assets
65.765.7961.8153.6553.9851.11
Long-Term Deferred Charges
1.951.843.767.6560.89
Other Long-Term Assets
6.387.668.7813.4320.4125.76
Total Assets
2,6202,5472,4702,5282,6062,352

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
334.99263.63213.09310.37314.47214.3
Accrued Expenses
11.0419.0210.2111.4628.869.9
Short-Term Debt
19.7621.71010--
Current Portion of Long-Term Debt
1.714.713.9213.8913.414.2
Current Portion of Leases
0.121.390.820.80.870.5
Current Income Taxes Payable
5.198.519.0827.4244.7444.26
Current Unearned Revenue
5050.7516.0547.0299.9335.91
Other Current Liabilities
70.7360.9396.5646.7440.2855.78
Total Current Liabilities
493.54440.62379.73467.69542.54374.84
Long-Term Debt
7.26.21526.640.3753.14
Long-Term Leases
3.031.511.051.350.970.81
Long-Term Unearned Revenue
231.2241.4256.1260.96278.15294.96
Long-Term Deferred Tax Liabilities
2.182.32.933.073.180.85
Total Liabilities
737.14692.03654.81759.67865.21724.59

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
510.66510.66510.66510.66510.66510.66
Additional Paid-In Capital
337.39337.39337.39337.38352.33343.51
Retained Earnings
1,013983.95940.88896.13854.47758.78
Comprehensive Income & Other
0.550.660.961.211.61.62
Total Common Equity
1,8621,8331,7901,7451,7191,615
Minority Interest
20.9422.7925.0923.0622.1712.92
Shareholders' Equity
1,8831,8551,8151,7681,7411,628
Total Liabilities & Equity
2,6202,5472,4702,5282,6062,352

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
31.845.4940.7952.6355.668.65
Net Cash (Debt)
602.82479357.1353.41344.26306.29
Net Cash Growth
69.72%34.13%1.04%2.66%12.39%-12.86%
Net Cash Per Share
1.180.940.700.690.670.60
Filing Date Shares Outstanding
510.66510.66510.66510.66510.66510.66
Total Common Shares Outstanding
510.66510.66510.66510.66510.66510.66
Working Capital
928.53892.12842.16771.18761.43659.79
Book Value Per Share
3.653.593.513.423.373.16
Tangible Book Value
1,7811,7501,7041,6571,6331,538
Tangible Book Value Per Share
3.493.433.343.243.203.01
Buildings
967.46946.04945.9938.67933.74927.81
Machinery
384.57382.57377.02366.31333.01317.82
Construction In Progress
--1.763.3--